Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

The Medicines Company UK Ltd
115L Milton Park, Abingdon, Oxfordshire, OX14 4SA, UK
Telephone: + 44 (0) 1235 448 500
Fax: + 44 (0) 1235 835 561
WWW: http://www.themedicinescompany.com
Medical Information Direct Line: + (00) 800 843 633 26
Medical Information e-mail: medical.information@themedco.com
Customer Care direct line: + (00) 800 843 633 26

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 27/02/2012
PIL Angiox 250mg powder for concentrate for solution for injection or infusion

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 27/02/2012 and displayed until Current
Reasons for adding or updating:
  • Change to MA holder contact details
Updated on 05/01/2012 and displayed until 27/02/2012
Reasons for adding or updating:
  • Change to name of manufacturer
  • Change to MA holder contact details
Updated on 05/01/2012 and displayed until 05/01/2012
Reasons for adding or updating:
  • Change to name of manufacturer
  • Change to MA holder contact details
Updated on 12/08/2010 and displayed until 05/01/2012
Reasons for adding or updating:
  • Change to packaging
Updated on 07/12/2009 and displayed until 12/08/2010
Reasons for adding or updating:
  • Changes to therapeutic indications
Updated on 29/06/2009 and displayed until 07/12/2009
Reasons for adding or updating:
  • Change to side-effects
Updated on 24/12/2008 and displayed until 29/06/2009
Reasons for adding or updating:
  • Change to MA holder contact details
Updated on 15/08/2008 and displayed until 24/12/2008
Reasons for adding or updating:
  • Change to side-effects
Updated on 21/02/2008 and displayed until 15/08/2008
Reasons for adding or updating:
  • Changes to therapeutic indications
  • Change to date of revision
  • Change to, or new, use for medicine
  • PIL Retired pending re-submission
Updated on 10/05/2007 and displayed until 21/02/2008
Reasons for adding or updating:
  • Change to side-effects
  • Change to Further Information section
Updated on 12/03/2007 and displayed until 10/05/2007
Reasons for adding or updating:
  • Change to packaging
Updated on 28/02/2007 and displayed until 12/03/2007
Reasons for adding or updating:
  • Change to packaging
  • Change to date of revision
Updated on 06/06/2006 and displayed until 28/02/2007
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 22/05/2006 and displayed until 06/06/2006
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
  bivalirudin